Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > AGEN Agenus > Main Composition
AGEN Agenus
2.700
+0.070+2.66%
Post Mkt Price
2.720
+0.020+0.74%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Research and development--244.42M82.67%
Non-cash royalty revenue related to the sale of future royalties--44.36M15.00%
Service revenue--6.7M2.27%
Other revenues--184K0.06%
Region Unit:USD
nameYOYOperating income%
United States--288.96M97.73%
Europe--6.7M2.27%
Company Overview More
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 31, 1994 and is headquartered in Lexington, MA.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Listing Date: 02/04/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist